Fiscal Year (FY) 2019/2020 NIH Strategic Plan for HIV and HIV-Related Research
The NIH Office of AIDS Research (OAR) recently released the FY 2019/2020 NIH Strategic Plan for HIV and HIV-Related Research. The Plan was developed in consultation with a broad network of HIV research stakeholders, including NIH and extramural scientific experts, advisory committee members, community representatives, and people with HIV (PWH).
Per its Congressional authorization, OAR coordinates the distribution of HIV research funds across the NIH Institutes, Centers, and Offices to advance the HIV research agenda, ensuring that those funds are aligned with the NIH HIV research priorities.
The priorities reflect the pipeline of scientific research—from basic discovery through translational, clinical, and implementation science research. This year’s Plan outlines opportunities to encourage new and ongoing investments and research partnerships to develop new strategies, improve existing efforts, and accelerate discovery. It is OAR’s goal that the strategies described in the Plan lead to innovative research efforts and a pipeline for discovery that will move us closer to ending the pandemic—helping us better meet the needs of people with, at risk for, and affected by HIV.
As part of the strong and sustained U.S. commitment to HIV research, the NIH leads global efforts to build on recent accomplishments, advance science, and conquer the HIV/AIDS pandemic. New avenues for discovery provide exciting possibilities for novel strategies to prevent, treat, manage, and eventually cure HIV.
I am honored to partner with you in the efforts to end the HIV/AIDS pandemic and improve the health of PWH.
Read the full Plan here.
Maureen M. Goodenow, Ph.D.
Associate Director for AIDS Research and
Director, Office of AIDS Research
National Institutes of Health
This page last reviewed on February 13, 2019